Next Article in Journal
The Effect of Isomaltulose Together with Green Tea on Glycemic Response and Antioxidant Capacity: A Single-Blind, Crossover Study in Healthy Subjects
Next Article in Special Issue
The Prevalence of Vitamin D Insufficiency and Deficiency and Their Relationship with Bone Mineral Density and Fracture Risk in Adults Receiving Long-Term Home Parenteral Nutrition
Previous Article in Journal
Characterization and Interrelations of One-Carbon Metabolites in Tissues, Erythrocytes, and Plasma in Mice with Dietary Induced Folate Deficiency
Previous Article in Special Issue
Trace Elements in Parenteral Nutrition: Considerations for the Prescribing Clinician
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessReview
Nutrients 2017, 9(5), 466;

Parenteral Nutrition and Intestinal Failure

Department of Public Health Sciences, Queen’s University, Kingston, ON K7L 3N6, Canada
Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto, ON M5G 2C4, Canada
Toronto General Hospital, University Health Network, Toronto, ON M5G 2C4, Canada
Author to whom correspondence should be addressed.
Received: 22 February 2017 / Revised: 11 April 2017 / Accepted: 19 April 2017 / Published: 6 May 2017
(This article belongs to the Special Issue Parenteral Nutrition 2016)
Full-Text   |   PDF [8659 KB, uploaded 6 May 2017]   |  


Severe short bowel syndrome (SBS) is a major cause of chronic (Type 3) intestinal failure (IF) where structural and functional changes contribute to malabsorption and risk of micronutrient deficiencies. Chronic IF may be reversible, depending on anatomy and intestinal adaptation, but most patients require long-term nutritional support, generally in the form of parenteral nutrition (PN). SBS management begins with dietary changes and pharmacologic therapies taking into account individual anatomy and physiology, but these are rarely sufficient to avoid PN. New hormonal therapies targeting intestinal adaptation hold promise. Surgical options for SBS including intestinal transplant are available, but have significant limitations. Home PN (HPN) is therefore the mainstay of treatment for severe SBS. HPN involves chronic administration of macronutrients, micronutrients, fluid, and electrolytes via central venous access in the patient’s home. HPN requires careful clinical and biochemical monitoring. Main complications of HPN are related to venous access (infection, thrombosis) and metabolic complications including intestinal failure associated liver disease (IFALD). Although HPN significantly impacts quality of life, outcomes are generally good and survival is mostly determined by the underlying disease. As chronic intestinal failure is a rare disease, registries are a promising strategy for studying HPN patients to improve outcomes. View Full-Text
Keywords: parenteral nutrition; intestinal failure; home parenteral nutrition; short bowel syndrome parenteral nutrition; intestinal failure; home parenteral nutrition; short bowel syndrome

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Bielawska, B.; Allard, J.P. Parenteral Nutrition and Intestinal Failure. Nutrients 2017, 9, 466.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top